Premier American Uranium Inc. (‘PUR’ or ‘Premier American Uranium’) (TSXV: PUR, OTCQB: PAUIF) and Nuclear Fuels Inc. (‘NF’ or ‘Nuclear Fuels’) (CSE: NF,…
Category:
Investing
-
-
Investing
Hempalta Announces Participation in the 2025 Canadian Climate Investor Conference
by adminHempalta (TSXV: HEMP), an agricultural clean-tech company that leverages its value chain and knowledge to generate global carbon credit solutions from industrial hemp…
-
Investing
Crypto Market Recap: DePIN Market expected to soar, Hong Kong seeks to expand its digital asset market
by adminHere’s a quick recap of the crypto landscape for Wednesday (June 4) as of 9:00 p.m. UTC. Get the latest insights on Bitcoin,…
-
Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on…
-
Metro Mining (MMI:AU) has announced Operational Update Download the PDF here. This post appeared first on investingnews.com
-
Cryptocurrency investors have experienced a real rollercoaster in the last few years — the likes of Bitcoin, Ethereum and Ripple have had incredible…
-
Investing
Juggernaut Announces Financing of $1,100,000 from Institutions and Accredited Investors
by admin(TheNewswire) Vancouver, British Columbia June 4 th 2025 TheNewswire – Juggernaut Exploration Ltd. (TSX-V: JUGR) (OTCQB: JUGRF) (FSE: 4JE) (the ‘Company’ or ‘Juggernaut’),…
-
Investing
Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah
by admintriumph gold Corp. (TSXV: TIG) (OTC Pink: TIGCF) (FSE: 8N6) (‘triumph gold’ or the ‘Company’) is pleased to announce the acquisition of the…
-
Investing
LaFleur Minerals Provides Swanson Gold Deposit and Beacon Mill Restart Update to Produce Gold and Announces Investor Call on June 5
by adminLaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) (‘LaFleur Minerals’ or the ‘Company’) is pleased to provide the results of its recent…
-
Investing
Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors
by adminPhase 1 1 First-In-Human study designed to assess safety , tolerability , right dose for Phase 2 and early signs…